Tocilizumab challenge: A series of cytokine storm therapy experiences in hospitalized COVID‐19 pneumonia patients

To recognize the period of exaggerated cytokine response in patients with coronavirus disease 2019 (COVID‐19) pneumonia, and to describe the clinical outcomes of using tocilizumab as a treatment option. The data of 12 adult COVID‐19 pneumonia patients who were followed in the inpatient clinics of Bi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Med Virol
Autori principali: Borku Uysal, Betul, Ikitimur, Hande, Yavuzer, Serap, Ikitimur, Baris, Uysal, Harun, Islamoglu, Mehmet Sami, Ozcan, Erkan, Aktepe, Emre, Yavuzer, Hakan, Cengiz, Mahir
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300754/
https://ncbi.nlm.nih.gov/pubmed/32484930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26111
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi